Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas
Oncotarget · 2024
DOI: 10.18632/oncotarget.28559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2024. Verfasst von Thomas M Cardillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunomedics, Inc., Morris Plains, NJ 07950 now acquired by Gilead Sciences, Inc., Foster City, CA 94404, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunoconjugates, Small Cell Lung Carcinoma, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunomedics, Inc., Morris Plains, NJ 07950 now acquired by Gilead Sciences, Inc., Foster City, CA 94404, USA.
- Gilead Sciences, Inc., Foster City, CA 94404, USA.
- At the time the work was conducted, all the authors were employees of Immunomedics, Inc.
- Current address: Center for Molecular Medicine and Immunology, Mendham, NJ 07945, USA; E-mail, dmg.gscancer@att.net.
- At the time the work was conducted, this author was Chairman and Chief Scientific Officer of Immunomedics, Inc., which he founded in 1982.
Zitieren
APA
Cardillo, T. M., Zalath, M. B., Arrojo, R., Sharkey, R. M., Govindan, S. V., Chang, C. H., & Goldenberg, D. M. (2024). Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas. Oncotarget. https://doi.org/10.18632/oncotarget.28559
Vancouver
Cardillo TM, Zalath MB, Arrojo R, Sharkey RM, Govindan SV, Chang CH, et al. Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas. Oncotarget. 2024. doi:10.18632/oncotarget.28559
BibTeX
@article{Cardillo2024,
author = {Cardillo, Thomas M and Zalath, Maria B and Arrojo, Roberto and Sharkey, Robert M and Govindan, Serengulam V and Chang, Chien-Hsing and Goldenberg, David M},
title = {Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas},
journal = {Oncotarget},
year = {2024},
doi = {10.18632/oncotarget.28559}
}
EUVIMED